An expert panel has recommended an expanded treatment envelope for the EPA drug Vascepa. An expert says the move won’t affect the supplement market directly but does add to recent official recognition of the health benefits of omega-3s.
FDA needs new tools to effectively deal with an expanding supplement marketplace, according to agency official Lowell Schiller. This is especially true when contemplating the flood of CBD products, with many more yet to come.
Before rushing into an amendment of DSHEA it’s wise to consider how the law has already been modified and how full enforcement of those provisions might accomplish what the modification advocates have in mind, a trade organization cautions.
A booming global market with double digit growth rates, establishing an adequate intake for dietary microbes, and why the impending taxonomic changes to the genus Lactobacillus are like Y2K: These were just some of the topics covered during the fourth...